COMPARISON OF THE POTENTIAL OF THE 2 EPIPODOPHYLLOTOXIN DERIVATIVES VP-16 AND VM-26 ON SMALL CELL-CANCER OF THE LUNG (SOCL) CELL-LINES

被引：0
|
作者：
ROED, H
VINDELOV, LL
CHRISTENSEN, IJ
HANSEN, HH
SPANGTHOMSEN, M
机构：
[1] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK
[2] UNIV COPENHAGEN,INST PATHOL ANAT,DK-1168 COPENHAGEN K,DENMARK
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：334 / 334
页数：1
相关论文
共 50 条
  • [41] THE ROLE OF VP-16 IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - STUDIES OF THE WEST OF SCOTLAND LUNG-CANCER GROUP
    BANHAM, S
    DORWARD, A
    HUTCHEON, A
    AHMEDZAI, S
    CUNNINGHAM, D
    BURNETT, A
    SOUKOP, M
    LUCIE, N
    KAYE, S
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 2 - 6
  • [42] EFFICACY OF IFOSFAMIDE AND VP-16 (ETOPOSIDE) IN PATIENTS WITH SMALL CELL LUNG CANCER AND THE CORRELATION BETWEEN MICROVESSEL COUNT ON CHEMOSENSITIVITY
    王斯闻
    刘宏旭
    李玉
    ChineseJournalofCancerResearch, 2006, (02) : 116 - 120
  • [43] CISPLATIN AND ETOPOSIDE (VP-16) AS A SINGLE REGIMEN FOR SMALL CELL LUNG-CANCER - A PHASE-II TRIAL
    BONI, C
    COCCONI, G
    BISAGNI, G
    CECI, G
    PERACCHIA, G
    CANCER, 1989, 63 (04) : 638 - 642
  • [44] VP-16 AND CIS-PLATINUM (P) COMBINATION CHEMOTHERAPY FOR RELAPSE IN SMALL CELL LUNG-CANCER (SCLC)
    OSOBA, D
    EVANS, WK
    FELD, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 495 - 495
  • [45] PHASE-II TRIAL OF CISPLATIN AND VP-16 IN PREVIOUSLY TREATED SMALL CELL LUNG-CANCER (SCLC)
    BATIST, G
    IHDE, DC
    COWAN, K
    VEACH, S
    GILLIOM, M
    BUNN, PA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 175 - 175
  • [46] Down-regulation of P-gp and drug resistance to csiplatin and VP-16 in human lung cancer cell lines
    Wang, Q.
    Wang, J.
    Zhang, J.
    Zhao, L. O. N. G.
    Zhang, L.
    EJC SUPPLEMENTS, 2010, 8 (05): : 67 - 67
  • [47] Down-regulation of P-Glycoprotein Is Associated with Resistance to Cisplatin and VP-16 in Human Lung Cancer Cell Lines
    Wang, Jiarui
    Wang, Huiling
    Zhao, Long
    Fan, Sufang
    Yang, Zhonghai
    Gao, Fei
    Chen, Lixia
    Xia, Gary Guishan
    Molnar, Joseph
    Wang, Qi
    ANTICANCER RESEARCH, 2010, 30 (09) : 3593 - 3598
  • [48] CIS-PLATINUM(DDP),VP-16(VP),ADRIAMYCIN(ADM) COMBINATION FOR INDUCTION IN SMALL CELL LUNG-CANCER (SCLC) CHEMOTHERAPY
    DEMARINIS, F
    MACCONE, C
    CARMINATI, F
    POMPILI, T
    PALLOTTA, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 46 - 46
  • [49] 2 SMALL CELL LUNG-CANCER CELL-LINES ESTABLISHED FROM RIGID BRONCHOSCOPE BIOPSIES
    POSTMUS, PE
    DELEY, L
    VANDERVEEN, AY
    MESANDER, G
    BUYS, CHCM
    ELEMA, JD
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 753 - &
  • [50] Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection
    Andoh, T
    Nishizawa, M
    Hida, T
    Ariyoshi, Y
    Takahashi, T
    Ueda, R
    ONCOLOGY RESEARCH, 1996, 8 (06) : 229 - 238
12345